Fundraising

For Fundraising enquires please contact Anna on 020 7487 3892, email [email protected] or write to us at

120 New Cavendish Street
London
W1W 6XX

Latest

Dr Heather Mortiboys and Dr Kevin McFarthing join CPT's Research Committee

The Cure Parkinson's Trust is pleased to announce two new additions to its Research Committee: Dr Heather Mortiboys and Dr Kevin McFarthing.
Autumn Research Update Meeting 2019

Presentations from our Autumn Research Update Meeting are now available to view.
Martin Wishart's Atlantic Sail for CPT

To mark the 20th anniversary of running his Edinburgh restaurant, Scottish Michelin Star Chef Martin Wishart will be taking on the incredible challenge of sailing 3,500 miles across the Atlantic in a bid to raise awareness and funds for The Cure Parkinson’s Trust.
Rachel's Party for Parkinson's Research

CPT's own Rachel Cunniffe held a fantastic ‘Party for Parkinson’s Research’ on Friday 1st November at Rickmansworth Lawn Tennis Club to help raise awareness and funds for CPT’s pioneering Parkinson’s research.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more